← Leaderboards
Darius N. Lakdawalla
Rand Corporation
$3,586,901
Attributed
$4,753,435
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $626.8K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,753,435 · 7
CDC$0 · 1
By mechanism
R01$4,320,642 · 3
R03$342,793 · 4
R13$90,000 · 1
Top collaborators
- Dana P Goldman4 shared
Most similar at Rand Corporation
Same institution · by research overlap
- Pinar Karaca-Mandic$4,055,014
- Dana P Goldman$26,931,376
- Roland Sturm$7,228,077
- Jack Zwangiger$0
- Arie Kapteyn$101,412,267
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposAffectEconomicsMedicalMedicineBaseFutureLiteratureTechnologyTrendSocialCostMedical TechnologyPolicy ResearchVariantAgingBehavioral /Social Science Research TagHealth EconomicsMalignant NeoplasmsIncentivesAmericanHuman DataInnovationElderly
Grant awards (18)
Ensuring Access to Novel Alzheimerâs and Dementia Treatments: Evaluating Innovative Payment Approaches$542,912
R01 · FY2021 · AG
Ensuring Access to Novel Alzheimerâs and Dementia Treatments: Evaluating Innovative Payment Approaches$546,875
R01 · FY2020 · AG
Ensuring Access to Novel Alzheimerâs and Dementia Treatments: Evaluating Innovative Payment Approaches$616,513
R01 · FY2019 · AG
Ensuring Access to Novel Alzheimerâs and Dementia Treatments: Evaluating Innovative Payment Approaches$626,769
R01 · FY2018 · AG
Medical Malpractice, Health Care Costs, and Technology Adoption$275,269
R01 · FY2012 · AG · contact PI
Medical Malpractice, Health Care Costs, and Technology Adoption$275,286
R01 · FY2011 · AG · contact PI
Medical Malpractice, Health Care Costs, and Technology Adoption$367,718
R01 · FY2010 · AG · contact PI
Medical Malpractice, Health Care Costs, and Technology Adoption$361,281
R01 · FY2009 · AG · contact PI
RAND Mini-Medical School for Social Scientists$90,000
R13 · FY2008 · AG · contact PI
WHOM DOES MEDICARE BENEFIT$235,358
R01 · FY2006 · AG · contact PI
EFFECT OF MEDICAL MALPRACTICE ON COSTS & TECH ADOPTION$83,500
R03 · FY2006 · AG · contact PI
WHOM DOES MEDICARE BENEFIT$240,646
R01 · FY2005 · AG
EFFECT OF MEDICAL MALPRACTICE ON COSTS &TECH ADOPTION$86,342
R03 · FY2005 · AG
WHOM DOES MEDICARE BENEFIT$232,015
R01 · FY2004 · AG
Unclaimed Injuries and Workers'Compensation Adequacy$0
R03 · FY2003 · OH
Unclaimed Injuries and Workers'Compensation Adequacy$0
R03 · FY2002 · OH
Age Difference of Spouses and Long-Term Care$86,538
R03 · FY2001 · AG
The Redistributive Effects of Medicare$86,413
R03 · FY2001 · AG